Loading data for PFSA — first visit, this takes a few seconds.
Profusa Inc. (PFSA)
NasdaqCM: PFSA
· Real-Time Price · USD
4.24
-0.01 (-0.24%)
At close: Aug 27, 2026, 3:59 PM
The price, the headline numbers and the latest news, in one place.
Profusa Inc. (PFSA) Stock Price, Analysis & Data
-0.24% (1D)
| Bid | 4.41 |
| Market Cap | 2.57M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -42.97M |
| 0.49 | |
| -922.06 | |
| n/a | |
| n/a | |
| P/B (ttm) | -0.01 |
| P/S (ttm) | n/a |
| Earnings Date | n/a |
| Ask | 6.9 |
| Volume | 342,300 |
| Avg. Volume (20D) | 1,081,140 |
| Open | 4.23 |
| Previous Close | 4.25 |
| Day's Range | 4.10 - 4.76 |
| 52-Week Range | 3.22 - 4500.00 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About PFSA
Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in ...
Industry Medical Devices
Sector Healthcare
IPO Date Jul 11, 2025
Employees n/a
Stock Exchange NasdaqCM
Ticker Symbol PFSA
Website https://profusa.com
Financial Performance
In 2025, Profusa's revenue was 0, an increase of undefined% compared to the previous year's 0. Earnings were -35.82M, an increase of 288.11%.
Financial Statements
Page 1 of 2